SCHEMBL2813804

SCHEMBL2813804

COc1ccc(CN2CCc3n[nH]c4nc(NCc5ccccc5Cl)nc2c34)cc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 1/20 0.42
HRH1 P35367 2/20 0.41
HRH4 Q9H3N8 2/20 0.41
CLPP Q16740 2/20 0.40
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
MAPK1 P28482 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MAPT P10636 2/20 0.37
KMT2A Q03164 1/20 0.37
GAA P10253 1/20 0.37
SIGMAR1 Q99720 1/20 0.36
TLR7 Q9NYK1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2809612 0.95 CXCR4 (0.41) CXCR4HRH1HRH4CLPPHTR2A
SCHEMBL537583 0.90 CLPP (0.49) HRH1HRH4CLPPTP53SMN1; SMN2
SCHEMBL2812929 0.88 CLK4 (0.43) HRH1HRH4CLPPLMNATP53
SCHEMBL2813934 0.85 CLPP (0.42) HRH1HRH4CLPPSMN1; SMN2KDM4E
SCHEMBL2810268 0.85 CLPP (0.42) HRH1HRH4CLPPSMN1; SMN2KDM4E
SCHEMBL2812343 0.84 CLPP (0.45) HRH1HRH4CLPPSMN1; SMN2KDM4E
SCHEMBL2816650 0.84 ALDH1A1 (0.43) HRH1HRH4CLPPKDM4EALDH1A1
SCHEMBL2812960 0.83 CLPP (0.40) HRH1HRH4CLPPKDM4EALDH1A1
SCHEMBL2813444 0.83 AXL (0.43) CLPPLMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL2812046 0.83 CLPP (0.39) HRH1HRH4CLPPKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS DPYD, TYMP, TP53 CXCR4 492/4885HRH1 2327/4885HRH4 1891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.